SECURITIES EXCHANGE AGREEMENTSecurities Exchange Agreement • May 11th, 2017 • Microbot Medical Inc. • Biological products, (no disgnostic substances) • New York
This Securities Exchange Agreement (this “Agreement”) is dated as of May 10, 2017, between Microbot Medical Inc. (f/k/a Stemcells, Inc.), a Delaware corporation (the “Company”), and the purchaser identified on the signature pages hereto (including its successors and assigns, the “Purchaser”).
